Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania
- PMID: 16931824
- DOI: 10.4269/ajtmh.2006.75.131
Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania
Abstract
We model the cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the Expanded Program on Immunization. We use a dynamic stochastic simulation model of the epidemiology of Plasmodium falciparum in malaria-endemic areas and of case management in Tanzania. We consider a range of vaccine characteristics and a range of transmission settings. At low vaccine prices, the cost-effectiveness of such vaccines may be similar to that of other established preventative and curative interventions against malaria. The cost-effectiveness ratio increases rapidly and approximately linearly with vaccine cost per dose. The approach can be adopted for comparative analyses of the cost effectiveness of different vaccines and other intervention strategies.
Similar articles
-
Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria.Value Health. 2011 Dec;14(8):1028-38. doi: 10.1016/j.jval.2011.06.004. Epub 2011 Aug 15. Value Health. 2011. PMID: 22152171
-
The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania.Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):119-30. doi: 10.4269/ajtmh.2006.75.119. Am J Trop Med Hyg. 2006. PMID: 16931823
-
Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa.Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):111-8. doi: 10.4269/ajtmh.2006.75.111. Am J Trop Med Hyg. 2006. PMID: 16931822
-
RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap.Vaccine. 2015 Dec 22;33(52):7425-32. doi: 10.1016/j.vaccine.2015.09.061. Epub 2015 Oct 1. Vaccine. 2015. PMID: 26431982 Review.
-
Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.Med Trop (Mars). 1995;55(4 Suppl):41-6. Med Trop (Mars). 1995. PMID: 8649265 Review.
Cited by
-
Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.Malar J. 2014 Feb 24;13:66. doi: 10.1186/1475-2875-13-66. Malar J. 2014. PMID: 24564883 Free PMC article.
-
Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings.Am J Trop Med Hyg. 2013 May;88(5):817-827. doi: 10.4269/ajtmh.12-0007. Epub 2013 Apr 15. Am J Trop Med Hyg. 2013. PMID: 23589530 Free PMC article.
-
Modeling the public health impact of malaria vaccines for developers and policymakers.BMC Infect Dis. 2013 Jul 1;13:295. doi: 10.1186/1471-2334-13-295. BMC Infect Dis. 2013. PMID: 23815273 Free PMC article.
-
Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment.Malar J. 2015 Oct 5;14:384. doi: 10.1186/s12936-015-0864-3. Malar J. 2015. PMID: 26437798 Free PMC article.
-
Agent-based models of malaria transmission: a systematic review.Malar J. 2018 Aug 17;17(1):299. doi: 10.1186/s12936-018-2442-y. Malar J. 2018. PMID: 30119664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources